Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 228

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 1A
Chunk 228
---
 with the Hemopurifier;

    ·
    failure to meet the continued listing requirements of and maintain our listing on Nasdaq;

    ·
    results of operations or revenue in any quarter failing to meet the expectations, published or otherwise, of the investment community;

 41 

    ·
    reduced investor confidence in equity markets;

    ·
    speculation in the press or analyst community;

    ·
    wide fluctuations in stock prices, particularly with respect to the stock prices for other medical device companies;

    ·
    announcements of technological innovations by us or our competitors;

    ·
    new products or the acquisition of significant customers by us or our competitors;

    ·
    changes in interest rates;

    ·
    changes in investors’ beliefs as to the appropriate price-earnings ratios for us and our competitors;

    ·
    changes in recommendations or financial estimates by securities analysts who track our common stock or the stock of other medical device companies;

    ·
    changes in management;

    ·
    sales of common stock by directors and executive officers;

    ·
    rumors or dissemination of false or misleading information, particularly through Internet chat rooms, instant messaging, and other rapid-dissemination methods;

    ·
    conditions and trends in the medical device industry generally;

    ·
    the announcement of acquisitions or other significant transactions by us or our competitors;

    ·
    adoption of new accounting standards affecting our industry;

    ·
    changes in the structure of healthcare payment systems;

    ·
    general market conditions;

    social and geopolitical incidents and issues; 

    ·
    domestic or international terrorism and other factors; and

    ·
    the other factors described in this section.

Fluctuations in the price
of our common stock may expose us to the risk of securities class action lawsuits. Although no such lawsuits are currently pending against
us and we are not aware that any such lawsuit is threatened to be filed in the future, future lawsuits are possible as a result of fluctuations
in the price of our common stock. Defending against any such suits could result in substantial cost and divert management’s attention
and resources. In addition, any settlement or adverse determination of such lawsuits could subject us to significant liability.

 42 

If at any time our common stock is subject
to the SEC’s penny stock rules, broker-dealers may experience difficulty in completing customer transactions and trading activity
in our securities may be adversely affected.

If at any time our common
stock is not listed on